Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Ethosomes for Dermal Administration of Natural Active Molecules

Author(s): Hiba Natsheh, Elisa Vettorato and Elka Touitou*

Volume 25, Issue 21, 2019

Page: [2338 - 2348] Pages: 11

DOI: 10.2174/1381612825666190716095826

Price: $65

Abstract

Ethosomes are nanovesicular carriers for dermal administration. Phospholipids, ethanol at relatively high concentrations (up to 50%) and water are their main components. Ethosomes are what we call “soft vesicles” with fluid bilayers due to the presence of ethanol. The composition and structure of the vesicles augment their ability to entrap molecules with various physicochemical properties and deliver them to the deep strata of skin. Since their first design, ethosomal systems have been extensively investigated for a wide range of applications.

This review focuses on work carried out in vitro, in vivo in animal models and in humans in clinical studies, with ethosomal formulations containing natural active molecules for the treatment of skin disorders. Skin bacterial and fungal infections, skin inflammation, acne vulgaris, arthritis, and skin cancer are examples of disorders managed successfully by ethosomal systems. Furthermore, Ethosomes loaded with a number of naturally occurring compounds for cosmetic applications are also reported. The efficient treatments together with a good safety profile and lack of toxicity or irritation paved the way towards the development of new dermal therapies.

Keywords: Ethosomes, soft vesicles, skin permeation, dermal administration, natural active molecules, skin disorders, dermal and regional delivery, cosmetic applications.

« Previous Next »
[1]
Schaefer H, Redelmeier TE. Skin barrier: Principles of percutaneous absorption. 1st ed. Basel: Karger AG 1996.
[2]
Barry WB. Dermatological formulations: Percutaneous absorption. New York, Basel: Marcel Dekker 1983.
[3]
Touitou E. Drug delivery across the skin. Expert Opin Biol Ther 2002; 2(7): 723-33.
[http://dx.doi.org/10.1517/14712598.2.7.723] [PMID: 12387671]
[4]
Braun-Falco O, Kortung HC, Maibach HI, Eds. Griesbach conference: Liposome dermatics. Berlin, Heidelberg: Springer-Verlag 1992.
[http://dx.doi.org/10.1007/978-3-642-48391-2]
[5]
Korting HC, Zienicke H, Schäfer-Korting M, Braun-Falco O. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990; 39(4): 349-51.
[http://dx.doi.org/10.1007/BF00315408] [PMID: 2076716]
[6]
Touitou E. inventor; Yissum Research Development Company, assignee. Composition for applying substances to or through the skin. United States patent 1998. US 5,716,638
[7]
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000; 65(3): 403-18.
[http://dx.doi.org/10.1016/S0168-3659(99)00222-9] [PMID: 10699298]
[8]
Godin B, Touitou E. Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 2003; 20(1): 63-102.
[http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v20.i1.20] [PMID: 12911264]
[9]
Touitou E, Godin B. Ethosomes for skin delivery. J Drug Deliv Sci Technol 2007; 17: 303-8.
[http://dx.doi.org/10.1016/S1773-2247(07)50046-8]
[10]
Touitou E, Godin B. Dermal drug delivery with ethosomes: Therapeutic potential. Therapy 2007; 4: 465-72.
[http://dx.doi.org/10.2217/14750708.4.4.465]
[11]
Touitou D, Godin B, Touitou E. Ethosomes- Efficiently delivering active agents to skin. Personal Care 2005; pp. 71-3.
[12]
Das SK, Chakraborty S, Roy C, et al. Ethosomes as novel vesicular carrier: An overview of the principle, preparation and its applications. Curr Drug Deliv 2018; 15(6): 795-817.
[http://dx.doi.org/10.2174/1567201815666180116091604] [PMID: 29336262]
[13]
Esposito E, Drechsler M, Nastruzzi C, Cortesi R. Cubic phases, cubosomes and ethosomes for cutaneous application. Curr Pharm Des 2016; 22(35): 5382-99.
[http://dx.doi.org/10.2174/1381612822666160726123227] [PMID: 27839503]
[14]
Ganesan P, Choi DK. Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy. Int J Nanomedicine 2016; 11: 1987-2007.
[http://dx.doi.org/10.2147/IJN.S104701] [PMID: 27274231]
[15]
Chang LW, Hou ML, Tsai TH. Silymarin in liposomes and ethosomes: pharmacokinetics and tissue distribution in free-moving rats by high-performance liquid chromatography-tandem mass spectrometry. J Agric Food Chem 2014; 62(48): 11657-65.
[http://dx.doi.org/10.1021/jf504139g] [PMID: 25375210]
[16]
Ramadon D, Wirarti GA, Anwar E. Novel transdermal ethosomal gel containing green tea (Camellia sinensis l. kuntze) leaves extract: formulation and in vitro penetration study. J Young Pharm 2017; 9: 336-40.
[http://dx.doi.org/10.5530/jyp.2017.9.67]
[17]
Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 2004; 94(2-3): 365-79.
[http://dx.doi.org/10.1016/j.jconrel.2003.10.014] [PMID: 14744487]
[18]
Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv 2005; 12(5): 297-303.
[http://dx.doi.org/10.1080/10717540500176910] [PMID: 16188729]
[19]
Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000; 21(18): 1879-85.
[http://dx.doi.org/10.1016/S0142-9612(00)00063-6] [PMID: 10919691]
[20]
Godin B, Touitou E. Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. Curr Drug Deliv 2005; 2(3): 269-75.
[http://dx.doi.org/10.2174/1567201054367931] [PMID: 16305429]
[21]
Shumilov M, Touitou E. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. Int J Pharm 2010; 387(1-2): 26-33.
[http://dx.doi.org/10.1016/j.ijpharm.2009.11.029] [PMID: 19961912]
[22]
Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001; 22(22): 3053-9.
[http://dx.doi.org/10.1016/S0142-9612(01)00052-7] [PMID: 11575480]
[23]
Esposito E, Menegatti E, Cortesi R. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosmet Sci 2004; 55(3): 253-64.
[http://dx.doi.org/10.1111/j.1467-2494.2004.00233_2.x] [PMID: 15264053]
[24]
Touitou E, Godin B, Shumilov M, et al. Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris. J Eur Acad Dermatol Venereol 2008; 22(5): 629-31.
[http://dx.doi.org/10.1111/j.1468-3083.2007.02398.x] [PMID: 18410627]
[25]
Yu Z, Lv H, Han G, Ma K. Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation. PLoS One 2016; 11(7)e0159967
[http://dx.doi.org/10.1371/journal.pone.0159967] [PMID: 27441661]
[26]
Marto J, Vitor C, Guerreiro A, et al. Ethosomes for enhanced skin delivery of griseofulvin. Colloids Surf B Biointerfaces 2016; 146: 616-23.
[http://dx.doi.org/10.1016/j.colsurfb.2016.07.021] [PMID: 27429295]
[27]
Bagchi D, Dutta S, Singh P, Chaudhuri S, Pal SK. Essential dynamics of an effective phototherapeutic drug in a nanoscopic delivery vehicle: psoralen in ethosomes for biofilm treatment. ACS Omega 2017; 2(5): 1850-7.
[http://dx.doi.org/10.1021/acsomega.7b00187] [PMID: 30023647]
[28]
Shetty S, Jose J, Kumar L, Charyulu RN. Novel ethosomal gel of clove oil for the treatment of cutaneous candidiasis. J Cosmet Dermatol 2018; (April): 1-8.
[PMID: 30171656]
[29]
Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005; 106(1-2): 99-110.
[http://dx.doi.org/10.1016/j.jconrel.2005.04.007] [PMID: 15935505]
[30]
Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res 2009; 19(2): 155-62.
[http://dx.doi.org/10.1080/08982100902722381] [PMID: 19241204]
[31]
Chen JG, Liu YF, Gao TW. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model. J Liposome Res 2010; 20(4): 297-303.
[http://dx.doi.org/10.3109/08982100903544144] [PMID: 20102297]
[32]
Shen LN, Zhang YT, Wang Q, Xu L, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm 2014; 460(1-2): 280-8.
[http://dx.doi.org/10.1016/j.ijpharm.2013.11.017] [PMID: 24269286]
[33]
Esposito E, Drechsler M, Huang N, et al. Ethosomes and organogels for cutaneous administration of crocin. Biomed Microdevices 2016; 18(6): 108-20.
[http://dx.doi.org/10.1007/s10544-016-0134-3] [PMID: 27830454]
[34]
Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J Control Release 2003; 93(3): 377-87.
[http://dx.doi.org/10.1016/j.jconrel.2003.09.001] [PMID: 14644587]
[35]
Fan C, Li X, Zhou Y, et al. Enhanced topical delivery of tetrandrine by ethosomes for treatment of arthritis. BioMed Res Int 2013; 2013161943
[http://dx.doi.org/10.1155/2013/161943] [PMID: 24062995]
[36]
Kumar Sarwa K, Rudrapal M, Mazumder B. Topical ethosomal capsaicin attenuates edema and nociception in arthritic rats. Drug Deliv 2015; 22(8): 1043-52.
[http://dx.doi.org/10.3109/10717544.2013.861041] [PMID: 24506573]
[37]
Ainbinder D, Touitou E. A new approach for skin tumor treatment: from delivery system characterization to in vivo evaluation. Drug Deliv Transl Res 2011; 1(1): 53-65.
[http://dx.doi.org/10.1007/s13346-010-0006-y] [PMID: 25787889]
[38]
Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Eur J Pharm Biopharm 2012; 81(1): 102-12.
[http://dx.doi.org/10.1016/j.ejpb.2012.02.008] [PMID: 22414731]
[39]
Celia C, Cilurzo F, Trapasso E, Cosco D, Fresta M, Paolino D. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomed Microdevices 2012; 14(1): 119-30.
[http://dx.doi.org/10.1007/s10544-011-9590-y] [PMID: 21960035]
[40]
Garg BJ, Garg NK, Beg S, Singh B, Katare OP. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target 2016; 24(3): 233-46.
[http://dx.doi.org/10.3109/1061186X.2015.1070855] [PMID: 26267289]
[41]
Touitou E, Godin B. Skin nonpenetrating sunscreens for cosmetic and pharmaceutical formulations. Clin Dermatol 2008; 26(4): 375-9.
[http://dx.doi.org/10.1016/j.clindermatol.2008.01.014] [PMID: 18691518]
[42]
Yeh MI, Huang HC, Liaw JH, et al. Ethosomes in hair dye products as carriers of the major compounds of black tea extracts. Int J Dermatol 2013; 52(7): 868-75.
[http://dx.doi.org/10.1111/ijd.12014] [PMID: 23676188]
[43]
Jeswani G, Saraf S. Topical Delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles. J Pharm Drug Deliv Res 2014; 03: 1-8.
[44]
Ascenso A, Pinho S, Eleutério C, et al. Lycopene from tomatoes: vesicular nanocarrier formulations for dermal delivery. J Agric Food Chem 2013; 61(30): 7284-93.
[http://dx.doi.org/10.1021/jf401368w] [PMID: 23826819]
[45]
Ma H, Guo D, Fan Y, Wang J, Cheng J, Zhang X. Paeonol-Loaded Ethosomes as Transdermal Delivery Carriers: Design, Preparation and Evaluation. Molecules 2018; 23(7): 1756-71.
[http://dx.doi.org/10.3390/molecules23071756] [PMID: 30018278]

Rights & Permissions Print Cite
Article Metrics
53
7
World Health Day
© 2024 Bentham Science Publishers | Privacy Policy